Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07467707 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened
    • Start date changed from estimate of May 2026 to May 26, 2026
    • Eligibility criteria shortened, about 25 words
    • Site details revised at 3 of 3 sites
    v3
  2. Study title expanded, about 1 wordv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Study EBSI-CV-317-007 is a field study to evaluate the efficacy, immunogenicity, and safety of CHIKV VLP vaccine. The study was designed using infectious disease models and advanced analytics to guide region and clinical site prioritization, define the timing of study activities, and optimize the study parameters to local epidemiological conditions for CHIKV disease to overcome the challenges of assessing efficacy for CHIKV VLP vaccine.
Trial Details
NCT Number NCT07467707
Lead Sponsor Bavarian Nordic
Collaborators: Walter Reed Army Institute of Research (WRAIR), Congressionally Directed Medical Research Programs, United States Department of Defense, Pharmaceutical Product Development, (PPD) LLC, Armed Forces Research Institute of Medical Services, Q-square Business Intelligence, Inc.
Conditions
(from sponsor)		 Chikungunya Virus
Related terms Chikungunya Fever
Enrollment 6,144 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov